• LAST PRICE
    1.7650
  • TODAY'S CHANGE (%)
    Trending Down-0.0950 (-5.1075%)
  • Bid / Lots
    1.7600/ 26
  • Ask / Lots
    1.7700/ 8
  • Open / Previous Close
    1.8400 / 1.8600
  • Day Range
    Low 1.7200
    High 1.8699
  • 52 Week Range
    Low 0.7912
    High 3.1200
  • Volume
    597,542
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.86
TimeVolumeCRDL
09:32 ET272361.8401
09:33 ET130991.8
09:35 ET1001.81
09:37 ET198281.79
09:39 ET93801.79
09:42 ET171211.8
09:44 ET51511.79
09:46 ET5451.7994
09:48 ET463741.795
09:50 ET2511.8
09:51 ET1001.795
09:53 ET21951.8
09:55 ET15001.795
09:57 ET10501.79
10:00 ET74721.78
10:02 ET2001.77
10:04 ET54991.79
10:06 ET15001.7841
10:08 ET16781.7708
10:09 ET65671.7747
10:11 ET3001.77
10:13 ET22371.765
10:15 ET53631.765
10:18 ET22001.76
10:20 ET46741.75
10:22 ET101751.77
10:24 ET75511.77
10:26 ET122111.77
10:27 ET25491.7701
10:33 ET55001.78
10:36 ET17991.77
10:38 ET1001.775
10:40 ET1001.775
10:42 ET17871.7789
10:44 ET4001.775
10:47 ET1001.78
10:49 ET3001.775
10:51 ET3001.78
10:54 ET2001.78
10:56 ET32001.7799
10:58 ET23001.77
11:00 ET2811.7788
11:02 ET3301.78
11:03 ET1001.78
11:05 ET1001.78
11:07 ET3001.7712
11:09 ET23001.77
11:12 ET476121.74
11:14 ET232721.75
11:16 ET185931.745
11:18 ET20001.75
11:20 ET163281.7299
11:21 ET4001.73
11:23 ET10001.73
11:25 ET21001.735
11:27 ET13101.735
11:30 ET24001.735
11:32 ET30001.735
11:34 ET10221.73
11:36 ET54001.735
11:38 ET45501.735
11:39 ET100991.74
11:41 ET52001.735
11:43 ET180221.725
11:48 ET53151.725
11:50 ET53291.725
11:52 ET7001.7294
11:54 ET33001.735
11:56 ET111001.735
11:57 ET36001.73
11:59 ET58411.725
12:01 ET6001.72
12:03 ET6001.725
12:06 ET61001.72
12:08 ET5001.72
12:10 ET3001.72
12:12 ET11001.72
12:14 ET45001.73
12:15 ET4781.725
12:17 ET60621.73
12:19 ET262001.725
12:21 ET5311.725
12:24 ET42081.74
12:28 ET1001.735
12:30 ET1001.735
12:32 ET21421.735
12:33 ET84651.74
12:35 ET4501.73
12:39 ET92741.7405
12:46 ET4151.7468
12:48 ET2291.7494
12:50 ET3001.7459
12:51 ET50141.74
01:02 ET7601.74
01:04 ET3001.74
01:06 ET3001.7398
01:08 ET14481.7442
01:09 ET15681.745
01:18 ET3001.745
01:20 ET5001.745
01:22 ET1001.745
01:26 ET26541.755
01:27 ET34001.75
01:29 ET51451.7454
01:31 ET164001.745
01:33 ET89731.755
01:36 ET14001.75
01:38 ET9591.7588
01:42 ET15001.7585
01:44 ET7001.755
01:45 ET1001.755
01:49 ET8071.755
01:51 ET2001.755
01:54 ET53001.755
01:56 ET1001.755
01:58 ET51711.755
02:00 ET2001.755
02:03 ET5001.76
02:05 ET2931.7597
02:12 ET2931.75
02:16 ET2001.755
02:18 ET1141.755
02:23 ET2001.755
02:27 ET1001.76
02:30 ET2001.755
02:32 ET32001.755
02:38 ET2001.7514
02:39 ET2001.755
02:43 ET51221.76
02:45 ET2861.765
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRDL
Cardiol Therapeutics Inc
209.3M
0.0x
---
As of 2024-11-15

Company Information

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

Contact Information

Headquarters
602-2265 Upper Middle Road EastOAKVILLE, ON, Canada L6H 0G5
Phone
289-910-0850
Fax
905-491-6793

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$209.3M
Revenue (TTM)
$0.00
Shares Outstanding
79.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.65
EPS
$-0.44
Book Value
$0.43
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.